Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 936 of 1,261
  1. US 8106232

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  2. US 8106082

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  3. US 8106160

    N-terminal modified interferon-alpha

    PHARMAESSENTIA CORPORATION · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  4. US 8101791

    Aminotetralin compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  5. US 8101766

    Crystalline form of a biphenyl compound

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  6. US 8101794

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  7. US 8101767

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  8. US 8101641

    Hydroxylated 1,2,4-oxadiazole benzoic acid compounds and compositions thereof

    PTC THERAPEUTICS, INC. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  9. US 8101198

    Osteogenic enhancer composition

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  10. US 8101380

    Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  11. US 8101382

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  12. US 8101186

    Peptides that block the binding of IgG to FcRn

    Syntonix Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  13. US 8101572

    Methods for promoting wound healing and/or reducing scar formation

    Arizona Board of Regents, A Corporate Body Organized Under Arizona Law · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  14. US 8101584

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  15. US 8101579

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  16. US 8101158

    Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity

    The Regents of the University of California · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  17. US 8101706

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Serina Therapeutics, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  18. US 8101770

    Pyridones useful as inhibitors of kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  19. US 8101647

    Spiro-oxindole compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  20. US 8101637

    Alkynyl derivatives as modulators of metatropic glutamate receptors

    Addex Pharma, S.A. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  21. US 8101575

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  22. US 8101567

    Heteroaryl-containing tripeptide HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  23. US 8101172

    Solenopsis invicta virus

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  24. US 8101630

    Extended release opioid abuse deterrent compositions and methods of making same

    Acurx Pharmaceuticals, Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.